David Weber - ABIOMED Scientific Advisor
Executive
Dr. David M. Weber is the Chief Operating Officer of the Company. Dr. Weber joined us in April 2007 as our Chief Operating Officer. Prior to joining us, Dr. Weber served as General Manager, Aviation Business at GE SecurityHomeland Protection from April 2005 until April 2007 where he led GE Securitys Aviation and Transportation Business and was responsible for product development, marketing and sales. From June 2004 until April 2005, he served as General Manager, MRI Marketing at GE Healthcare where he was responsible for strategic product planning, gotomarket and product launch activities, including developing product roadmaps and introducing new product technologies to the market, and from March 2001 until June 2004, he served as Manager, Global High Field MRI Business, GE Medical Systems where he was responsible for new product planning and development since 2007.
| Age | 62 |
| Tenure | 18 years |
| Phone | 978 777-8411 |
| Web | www.abiomed.com |
David Weber Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Weber against ABIOMED stock is an integral part of due diligence when investing in ABIOMED. David Weber insider activity provides valuable insight into whether ABIOMED is net buyers or sellers over its current business cycle. Note, ABIOMED insiders must abide by specific rules, including filing SEC forms every time they buy or sell ABIOMED'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Weber over a year ago Sale by David Weber of 920 shares of Northwest Natural | ||
David Weber over a year ago Payment of 406 shares by David Weber of Northwest Natural subject to Rule 16b-3 | ||
David Weber over a year ago Acquisition by David Weber of 907 shares of Northwest Natural subject to Rule 16b-3 | ||
David Weber over a year ago Acquisition by David Weber of 805 shares of Northwest Natural subject to Rule 16b-3 |
ABIOMED Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1824 %, meaning that it created $0.1824 on every $100 dollars invested by stockholders. ABIOMED's management efficiency ratios could be used to measure how well ABIOMED manages its routine affairs as well as how well it operates its assets and liabilities.ABIOMED currently holds 10 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. ABIOMED has a current ratio of 7.38, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ABIOMED's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Marisol Leniz | Compania Cervecerias Unidas | 60 | |
| Traci Mangini | Molson Coors Brewing | 55 | |
| Turner Caldwell | Tesla Inc | N/A | |
| Sofia Colucci | Molson Coors Brewing | N/A | |
| Brian Erhardt | Molson Coors Brewing | N/A | |
| Vaibhav Taneja | Tesla Inc | 47 | |
| Barbara Wolff | Compania Cervecerias Unidas | 49 | |
| Beyza Sarioglu | Visteon Corp | N/A | |
| Rahul Goyal | Molson Coors Brewing | N/A | |
| Brian Scelfo | Tesla Inc | N/A | |
| Jeffrey Straubel | Tesla Inc | 48 | |
| Felipe Almarza | Compania Cervecerias Unidas | 44 | |
| Phil McBride | SNDL Inc | N/A | |
| Lars Moravy | Tesla Inc | N/A | |
| Alexandre Conde | ScanSource | N/A | |
| Andrew Baglino | Tesla Inc | 43 | |
| Colleen Myers | Visteon Corp | 49 | |
| Robert Farbak | ScanSource | N/A | |
| Sophie Pilon | SNDL Inc | N/A | |
| Felipe Azocar | Compania Cervecerias Unidas | 55 | |
| Deanna Garand | SNDL Inc | 42 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 |
ABIOMED Leadership Team
Elected by the shareholders, the ABIOMED's board of directors comprises two types of representatives: ABIOMED inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ABIOMED. The board's role is to monitor ABIOMED's management team and ensure that shareholders' interests are well served. ABIOMED's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ABIOMED's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Howley, VP and General Manager of Global Sales | ||
| Michael Minogue, Chairman, CEO and President Member of Special Stock Option Committee and Member of Executive Committee | ||
| Andrew Greenfield, Vice President - Healthcare Solutions | ||
| Thorsten Siess, Ex Officer | ||
| Ingrid Ward, Director Relations | ||
| Matthew Plano, Ex Integration | ||
| Todd Trapp, CFO, Vice President | ||
| Sarah Karr, Communications Mang | ||
| Marc Began, Gen VP | ||
| David Weber, Scientific Advisor |
ABIOMED Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ABIOMED a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 16.32 B | |||
| Shares Outstanding | 45.09 M | |||
| Shares Owned By Insiders | 2.02 % | |||
| Shares Owned By Institutions | 97.00 % | |||
| Number Of Shares Shorted | 753.62 K | |||
| Price To Earning | 76.38 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |